The cost of antiretroviral treatment service for patients with HIV/AIDS in a central outpatient clinic in Vietnam

Long Thanh Nguyen; Bach Xuan Tran; Cuong Tuan Tran; Huong Thi Le; Son Van Tran
February 2014
ClinicoEconomics & Outcomes Research;2014, Vol. 6, p101
Academic Journal
Introduction: Antiretroviral treatment (ART) services are estimated to account for 30% of the total resources needed for human immunodeficiency virus (HIV)/acquired immunodeficiency syndrome (AIDS) control and prevention in Vietnam during the 2011-2020 timeframe. With international funding decreasing, determining the total cost of HIV/AIDS treatment is necessary in order to develop a master plan for the transition of ART services delivery and management. We analyzed the costs of HIV/AIDS treatment paid by both HIV programs and patients in a central outpatient clinic, and we explored factors associated with the capacity of patients to pay for this service. Methods: Patients (n=315) receiving ART in the Department of Infectious Diseases at Bach Mai Hospital, Hanoi, Vietnam, were interviewed. Patient records and expenses were reviewed. Results: The total cost of ART per patient was US$611 (75% from health care providers, 25% from patients or their families). The cost of a second-line regimen was found to be 2.7 times higher than the first-line regimen cost. Most outpatients (73.3%) were able to completely pay for all of their ART expenses. Capacity to pay for ART was influenced by five factors, including marital status, distance from house to clinic, patient's monthly income, household economic condition, and health insurance status. Most of the patients (84.8%) would have been willing to pay for health insurance if a copayment scheme for ART were to be introduced. Conclusion: This study provides evidence on payment capacity of HIV/AIDS patients in Vietnam and supplies information on ART costs from both provider and patient perspectives. In particular, results from this study suggest that earlier access to ART after HIV infection could dramatically reduce the overall cost of treatment.


Related Articles

  • HIV guidelines updated. Dalton, Paul // Bay Area Reporter;12/6/2007, Vol. 37 Issue 49, p6 

    The author reports on the changes made to the "Guidelines for the Use of Antiretrovirals in HIV-1 Infected Adults and Adolescents." He states that the revision reflects important shifts in advice concerning the treatment of HIV/AIDS. He stresses that such guidance helps physicians and people...

  • Improving health outcomes through concurrent HIV program scale-up and health system development in Rwanda: 20 years of experience. Nsanzimana, Sabin; Prabhu, Krishna; McDermott, Haley; Karita, Etienne; Forrest, Jamie I.; Drobac, Peter; Farmer, Paul; Mills, Edward J.; Binagwaho, Agnes // BMC Medicine;9/10/2015, Vol. 13 Issue 1, p1 

    The 1994 genocide against the Tutsi destroyed the health system in Rwanda. It is impressive that a small country like Rwanda has advanced its health system to the point of now offering near universal health insurance coverage. Through a series of strategic structural changes to its health...

  • Trends in Decline of Antiretroviral Resistance among ARV-Experienced Patients in the HIV Outpatient Study:1999-2008. Buchacz, Kate; Baker, Rose; Ward, Douglas J.; Palella, Frank J.; Chmiel, Joan S.; Young, Benjamin; Yangco, Bienvenido G.; Novak, Richard M.; Brooks, John T. // AIDS Research & Treatment;2012, p1 

    Background. Little is known about temporal trends in frequencies of clinically relevant ARV resistance mutations in HIV strains from U.S. patients undergoing genotypic testing (GT) in routine HIV care. Methods. We analyzed cumulative frequency of HIV resistance among patients in the HIV...

  • Barriers and Facilitators for Adherence to Antiretroviral Therapy in Papua New Guinea. Kelly, A.; Worth, H.; Man, N.; Nosi, S.; Emori, R.; Mek, A.; Akuani, F.; Kupul, M.; Kepa, B.; Walizopa, L.; Pirpir, L.; Cangah, B.; Siba, P.; Frankland, A.; Rawstorne, P. // Current HIV Research;Dec2010, Vol. 8 Issue 8, p630 

    No abstract available.

  • Intervening in global markets to improve access to HIV/AIDS treatment: an analysis of international policies and the dynamics of global antiretroviral medicines markets. Brenda Waning; Margaret Kyle; Ellen Diedrichsen; Lyne Soucy; Jenny Hochstadt; Till Bärnighausen; Moon, Suerie // Globalization & Health;2010, Vol. 6, p9 

    Background: Universal access to antiretroviral therapy (ART) in low- and middle-income countries faces numerous challenges: increasing numbers of people needing ART, new guidelines recommending more expensive antiretroviral (ARV) medicines, limited financing, and few fixed-dose combination (FDC)...

  • Ask he Pharmacist. Oviawe, Marvin // Word (Word Publications - Ted Fleischaker);Jan2011, p27 

    The author discusses the need to take medications on time in order to assure favorable outcomes in HIV patients. He says that patient readiness to begin taking HIV medications on time is a critical step in keeping HIV/AIDS under control. He adds that the chance of surviving longer increases when...

  • The provision of TB and HIV/AIDS treatment support by lay health workers in South Africa: a time-and-motion study. Odendaal, Willem A.; Lewin, Simon // Human Resources for Health;2014, Vol. 12 Issue 1, p1 

    Background Lay or community health workers (LHWs) are an important human resource in primary health care, and contribute to improving access to care. However, optimal use of LHWs within the health system is often hampered by a poor understanding of how this cadre organizes its work. This study...

  • "RANTES- A NEW TARGET FOR FIGHTING AGAINST HIV INFECTION". WASNIK, KIRTI // International Journal of Pharma & Bio Sciences;Apr-Jun2011, Vol. 2 Issue 2, pP.491 

    Although treatments for AIDS and HIV can slow the course of the disease, there is currently no vaccine or cure. Antiretroviral treatment reduces both the mortality and the morbidity of HIV infection, but these drugs are expensive and routine access to antiretroviral medication is not available...

  • Here come the drugs.  // U.S. Catholic;Apr2004, Vol. 69 Issue 4, p10 

    Reports on the free antiretroviral drugs given by the Catholic Church to South Africans infected with HIV and AIDS. Number of South Africans infected; Plan for the church-run projects for the drugs; Statement from Bishop Kevin Dowling about the proposed antiretroviral drug program from the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics